Although enriched networks (Fig. 3) are not directly related to known metformin effects, the downstream molecules of those associated with differential methylation levels in our study group are known to be involved in various pathways related with T2D (e.g., AKT, ERK1/2, JNK, P13K), insulin regulation processes [77], cancer development mechanisms [78], and other. Here, MAPK3 is linked to cancer.